Dylan Weil is a senior scientist specializing in bioassay development at AstraZeneca. With a Bachelor of Science in Molecular Bioscience and Biotechnology from Rochester Institute of Technology and a Master of Science in Biotechnology, Bioinformatics from Johns Hopkins University, Dylan has extensive laboratory experience across various disciplines including cell culture, genetic engineering, and immunology. Prior roles include research associate positions at IDT Biologika and Aeras, where Dylan focused on assay development and characterizing recombinant vaccines. Currently, Dylan is engaged in developing and implementing advanced bioassays and incorporating machine learning tools to enhance data analysis workflows.
This person is not in the org chart
This person is not in any teams
This person is not in any offices